TAMs promote tumor progression via key signaling pathways, including TGF-β/BMP, TNF-α/Wnt, IL-6/STAT3/IRF4, and Wnt/β-catenin, each regulating cell motility, survival, and immune suppression (48, 52, 53). Here, TGFB1 is linked to neoplasm.